Please assess the completion status of the following clinical trial:

Trial Title: Melatonin Supplementation in Postmenopausal Women With H. Pylori-associated Dyspepsia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Patients with~* Epigastric pain of a hunger nature~* Pain at night in the epigastric region~* Increased appetite~Exclusion Criteria:~Patients with~* Functional or inflammatory diseases of the gastrointestinal tract liver and pancreas~* Metabolic, allergic and mental disease~* Hormone replacement therapy

- Gender: FEMALE
- Minimum Age: 49 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): Melatonin ( 5-Methoxy-N-Acetyltryptamine) at dose 1mg/morning and 3mg/at bedtime (period 6 months)
- Placebo (Type: PLACEBO_COMPARATOR): 1 tablet twice daily (period 6 months)
- Helicobacter pylori infected group (Type: OTHER): Pantoprazole 2 x 40mg (twice daily) Amoxicyllin 2 x 1000mg (twice daily) Lovofloxacin 2 x 500mg (twice daily)

Based on this trial design, predict the completion outcome and termination type (if applicable).